Acknowledgement to Referees.

The final issue of Drug Safety for 2023 reflects on the achievements of the year and expresses gratitude to all those who contributed to the journal. The high quality of content published in Drug Safety is evident in its Journal Impact Factor of 4.2 and CiteScore™ of 8.2. The journal has also published articles in a timely manner, with a median time from submission to first decision of 17 days. The editor acknowledges the diligence of the peer reviewers and lists the individuals who acted as reviewers in the last 12 months. The editorial schedule for 2024 is already in progress, promising more high-quality articles in the coming year. [Extracted from the article]